J&J Q3 ADJ EPS $2.59 VS IBES ESTIMATE $2.54 || SALES $25.40 BLN VS IBES ESTIMATE $25.28 BLN || TREMFYA WORLDWIDE SALES $2.40 BLN || MEDTECH SALES $8.64 BLN || Q3 STELARA WORLDWIDE SALES $716 MLN; DARZALEX WORLDWIDE SALES $4.24 BLN || EPS OF $0.09 REFLECTS ONE-TIME SPECIAL CHARGE FOR TALC LITIGATION RESOLUTION , FIREFLY BIO ACQUISITION, SAIL BIOMEDICINES COLLABORATION 13-OCT-2026 06:22 AM ET